Trial Profile
A Randomized, Open-Label, Comparative, Two-Treatment, Crossover Study of the 24-Hour Intragastric pH Profile After 5 Days of Once Daily Oral Administration of Either Esomeprazole 40 Mg or Pantoprazole 40 Mg Following Once Daily Infusion of Intravenous Pantoprazole 40 Mg for 5 Days in Healthy Volunteer Subjects
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Apr 2009
Price :
$35
*
At a glance
- Drugs Esomeprazole (Primary) ; Pantoprazole; Pantoprazole
- Indications Gastro-oesophageal reflux
- Focus Pharmacodynamics
- Sponsors AstraZeneca
- 09 Sep 2008 New trial record.